🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II pilot study of chemotherapy and surgery for children wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-10
Trial ID
NCT00186849
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
Objective of the study objectives was to explore survival advantage for an ...
Status
Terminated
Location
Institut Gustave Roussy
Start Date
1995-07
Trial ID
NCT00162695
Treatments Being Tested
This phase II trial studies how well combination chemotherapy works in trea...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-19
Trial ID
NCT04322318
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as mitoxantrone hydrochloride, ...
Status
Completed
Location
Ematologia con trapianto- AOU Policlinico Consorziale di Bari
Start Date
2010-10
Trial ID
NCT01154439
Treatments Being Tested
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
The purpose of this study is to improve outcome of high risk neuroblastoma ...
Status
Unknown
Location
Samsung Medical Center
Start Date
2015-04
Trial ID
NCT02771743
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested